Skip to content
DraconiticResearch
Search Sources API
197,783 studies31 sourcesUpdated 9 min ago
Peer-reviewedCC BY-NC-NDBlood neoplasia

Kinetic BCR::ABL1 reduction by transcript types in frontline CML treatment: a GIMEMA LabNet CML network survey

  • Fabio Stagno1
  • Rosalba Cucci2
  • Giovanni Marsili2
  • Fausto Castagnetti3
  • Sara Galimberti4
  • Barbara Izzo5
  • Federica Sorà6
  • Simona Soverini3
  • Monica Messina2
  • Alfonso Piciocchi2
  • Massimiliano Bonifacio7
  • Daniela Cilloni8
8 more authors
  • Alessandra Iurlo9
  • Giovanni Martinelli3
  • Paola Fazi2
  • Marco Vignetti2
  • Massimo Breccia10
  • Alessandro Allegra1
  • Gianantonio Rosti11
  • Fabrizio Pane12
12 affiliations
  1. 1Hematology Section, AOU Policlinico G. Martino, University of Messina, Messina, Italy
  2. 2Fondazione GIMEMA, Rome, Italy
  3. 3Department of Medical and Surgical Sciences, Institute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italy
  4. 4Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
  5. 5Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università Degli Studi di Napoli Federico II, Naples, Italy
  6. 6Institute of Hematology, Dipartimento di Scienze di Laboratorio ed Ematologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Università Cattolica del Sacro Cuore, Rome, Italy
  7. 7Hematology Area, Section of Innovation Biomedicine, Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy
  8. 8SCDU Hematology and Cellular Therapies, AO Ordine Mauriziano di Torino, Turin, Italy
  9. 9Hematology Unit, Foundation IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy
  10. 10Department of Translational and Precision Medicine, Azienda Policlinico Umberto I, Sapienza University, Rome, Italy
  11. 11IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy
  12. 12Division of Hematology and Bone Marrow Transplantation, Department of Medicine and Surgery, University of Naples Federico II, Naples, Italy
Read full textPDFCite

Related

  1. Lorlatinib in frontline treatment of advanced ALK-positive non-small cell lung cancer: a highly efficient new standard of care but still challenging to manage
    Mylène Wespiser, Aurélie Swalduz, Maurice Pérol
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDGeneral biologyOncologyHAL
  2. Shortened Obinutuzumab Infusion Is Safe and Reduces Chair Time in Frontline Treatment of Chronic Lymphocytic Leukemia: A Real-World Study.
    Dominika Écsiová, Eva Vejražková, Pavel Vodárek +4
    Cancer medicinePeer-reviewedCC BY-NCFull textHuman geneticsEurope PMCPMC
  3. Exploratory Interim Analysis of Serial Plasma and Single-Follicle Follicular Fluid Oxidation–Reduction Potential During Fertility Treatment
    Aris Kaltsas, Stamatis Papaharitou, Kyriakos Papanikolaou +2
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Effects of percutaneous kyphoplasty with concomitant postural reduction in the treatment of acute osteoporotic vertebral compression fractures
    Yulin Chen, Peng Yang, Ankejiang Anniwaer +4
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity
    Leili Gao, H X Jiang, Hanqing Cai +32
    JAMAPeer-reviewedLicence not stated9 citedPharmacology & toxicologyOpenAlex

Cite

BibTeXRIS
BibTeX
@article{stagno2026kinetic,
  title = {{Kinetic BCR::ABL1 reduction by transcript types in frontline CML treatment: a GIMEMA LabNet CML network survey}},
  author = {Fabio Stagno and Rosalba Cucci and Giovanni Marsili and Fausto Castagnetti and Sara Galimberti and Barbara Izzo and Federica Sorà and Simona Soverini and Monica Messina and Alfonso Piciocchi and Massimiliano Bonifacio and Daniela Cilloni and Alessandra Iurlo and Giovanni Martinelli and Paola Fazi and Marco Vignetti and Massimo Breccia and Alessandro Allegra and Gianantonio Rosti and Fabrizio Pane},
  journal = {Blood neoplasia},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13657216},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Kinetic BCR::ABL1 reduction by transcript types in frontline CML treatment: a GIMEMA LabNet CML network survey
AU  - Fabio Stagno
AU  - Rosalba Cucci
AU  - Giovanni Marsili
AU  - Fausto Castagnetti
AU  - Sara Galimberti
AU  - Barbara Izzo
AU  - Federica Sorà
AU  - Simona Soverini
AU  - Monica Messina
AU  - Alfonso Piciocchi
AU  - Massimiliano Bonifacio
AU  - Daniela Cilloni
AU  - Alessandra Iurlo
AU  - Giovanni Martinelli
AU  - Paola Fazi
AU  - Marco Vignetti
AU  - Massimo Breccia
AU  - Alessandro Allegra
AU  - Gianantonio Rosti
AU  - Fabrizio Pane
PY  - 2026
DA  - 2026/08/24
JO  - Blood neoplasia
UR  - https://europepmc.org/article/PMC/PMC13657216
SN  - 2950-3280
ER  -